Dr. Waples is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Cci Dr Nw
Huntsville, AL 35805Phone+1 256-705-4224Fax+1 256-705-4135
Education & Training
- University of FloridaFellowship, Hematology and Medical Oncology, 1995 - 1998
- University of FloridaResidency, Internal Medicine, 1992 - 1995
- University of Florida College of MedicineClass of 1992
Certifications & Licensure
- AL State Medical License 1998 - 2025
- TN State Medical License 2013 - 2016
- FL State Medical License 1994 - 2000
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Clinical Trials
- Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma Start of enrollment: 2003 Oct 01
- Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS) Start of enrollment: 2004 Feb 01
- A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC Start of enrollment: 2005 Nov 01
Publications & Presentations
PubMed
- 7 citationsA phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphoma.Bradley J. G. Larson, John M. Waples, Annette Pusateri, Nancy P. Mendenhall, James W. Lynch
American Journal of Clinical Oncology. 2005-04-01 - 19 citationsManagement of a patient with a mechanical aortic valve and antibodies to both thrombin and factor V after repeat exposure to fibrin sealant.Marc Zumberg, John M. Waples, K.J. Kao, Richard Lottenberg
American Journal of Hematology. 2000-05-01
Press Mentions
- OneOncology Partners With Huntsville's Clearview Cancer InstituteJanuary 17th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: